FI4039688T3 - Substituoidut pyrrolopyrimidiini ja pyratsolopyrimiiini Brutonin tyrodiinikinaasin (BTK) hajottajina - Google Patents
Substituoidut pyrrolopyrimidiini ja pyratsolopyrimiiini Brutonin tyrodiinikinaasin (BTK) hajottajina Download PDFInfo
- Publication number
- FI4039688T3 FI4039688T3 FIEP22154786.2T FI22154786T FI4039688T3 FI 4039688 T3 FI4039688 T3 FI 4039688T3 FI 22154786 T FI22154786 T FI 22154786T FI 4039688 T3 FI4039688 T3 FI 4039688T3
- Authority
- FI
- Finland
- Prior art keywords
- fluoro
- dioxopiperidin
- methoxybenzamide
- pyrazolo
- piperazin
- Prior art date
Links
- 102000001714 Agammaglobulinaemia Tyrosine Kinase Human genes 0.000 title 1
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 title 1
- OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical class C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 title 1
- 239000001064 degrader Substances 0.000 title 1
- 150000004944 pyrrolopyrimidines Chemical class 0.000 title 1
- PBBBTBKBIDWLIR-BHVANESWSA-N COC(C=CC(F)=C1)=C1C(NCC(C=C1)=CC=C1C1=NN(C(C2)CN2C2=NC=C(CN(CC3)CCN3C(C=C3CN4[C@@H](CCC(N5)=O)C5=O)=CC=C3C4=O)C=C2)C2=NC=NC(N)=C12)=O Chemical compound COC(C=CC(F)=C1)=C1C(NCC(C=C1)=CC=C1C1=NN(C(C2)CN2C2=NC=C(CN(CC3)CCN3C(C=C3CN4[C@@H](CCC(N5)=O)C5=O)=CC=C3C4=O)C=C2)C2=NC=NC(N)=C12)=O PBBBTBKBIDWLIR-BHVANESWSA-N 0.000 claims 1
- ILOMLHZESRWACU-FAIXQHPJSA-N COC(C=CC(F)=C1)=C1C(NCC(C=C1)=CC=C1C1=NN(C(CC2)CCN2C2=CC=C(CN(CC3)CCN3C(C=C3CN4[C@@H](CCC(N5)=O)C5=O)=CC=C3C4=O)C=C2)C2=NC=NC(N)=C12)=O Chemical compound COC(C=CC(F)=C1)=C1C(NCC(C=C1)=CC=C1C1=NN(C(CC2)CCN2C2=CC=C(CN(CC3)CCN3C(C=C3CN4[C@@H](CCC(N5)=O)C5=O)=CC=C3C4=O)C=C2)C2=NC=NC(N)=C12)=O ILOMLHZESRWACU-FAIXQHPJSA-N 0.000 claims 1
- XBYJVCGPJASMOS-CRGCAJGSSA-N COC(C=CC(F)=C1)=C1C(NCC(C=C1)=CC=C1C1=NN(C(CC2)CN2C(CCCCN(CC2)CCN2C(C=C2CN3[C@@H](CCC(N4)=O)C4=O)=CC=C2C3=O)=O)C2=NC=NC(N)=C12)=O Chemical compound COC(C=CC(F)=C1)=C1C(NCC(C=C1)=CC=C1C1=NN(C(CC2)CN2C(CCCCN(CC2)CCN2C(C=C2CN3[C@@H](CCC(N4)=O)C4=O)=CC=C2C3=O)=O)C2=NC=NC(N)=C12)=O XBYJVCGPJASMOS-CRGCAJGSSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163145126P | 2021-02-03 | 2021-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI4039688T3 true FI4039688T3 (fi) | 2024-12-19 |
Family
ID=80447078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP22154786.2T FI4039688T3 (fi) | 2021-02-03 | 2022-02-02 | Substituoidut pyrrolopyrimidiini ja pyratsolopyrimiiini Brutonin tyrodiinikinaasin (BTK) hajottajina |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11530222B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4501327A3 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024505558A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230142539A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117042769A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3209082A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK4039688T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3010513T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI4039688T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023008865A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022169798A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202317099A (zh) * | 2020-09-10 | 2023-05-01 | 美商絡速藥業公司 | 用於製備(s)-5-胺基-3-(4-((5-氟-2-甲氧基苯甲醯胺基)甲基)苯基)-1-(1,1,1-三氟丙烷-2-基)-1h-吡唑-4-甲醯胺之方法及中間體 |
| EP4452945A2 (en) * | 2021-12-20 | 2024-10-30 | Sigma-Aldrich Co. LLC | Chemical linkers |
| WO2023235691A1 (en) * | 2022-05-31 | 2023-12-07 | Accutar Biotechnology, Inc. | Btk reducing molecules for treatment of cancers and immune system disorders |
| WO2024169871A1 (zh) * | 2023-02-17 | 2024-08-22 | 江苏威凯尔医药科技有限公司 | Btk抑制剂及其用途 |
| CN120051475A (zh) * | 2023-05-26 | 2025-05-27 | 广东弘烨医药科技有限公司 | 9元杂芳基化合物、含其的药物组合物及其制备方法和应用 |
| KR20260041885A (ko) | 2023-07-25 | 2026-03-27 | 몬테 로사 테라퓨틱스 아게 | 표적화된 단백질 분해를 위한 치환된 피페리딘디온 |
| CN120535526A (zh) * | 2024-02-26 | 2025-08-26 | 中国药科大学 | 直接结合蛋白酶体的非泛素依赖型蛋白水解靶向嵌合体NuTAC及其应用 |
| WO2026040951A1 (zh) * | 2024-08-19 | 2026-02-26 | 深圳市塔吉瑞生物医药股份有限公司 | 靶向btk蛋白降解靶向嵌合体类化合物及其组合物及用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114946A (en) | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
| US4818541A (en) | 1987-08-19 | 1989-04-04 | Schering Corporation | Transdermal delivery of enantiomers of phenylpropanolamine |
| CN105017256A (zh) * | 2014-04-29 | 2015-11-04 | 浙江导明医药科技有限公司 | 多氟化合物作为布鲁顿酪氨酸激酶抑制剂 |
| CN106146511A (zh) * | 2015-04-03 | 2016-11-23 | 安润医药科技(苏州)有限公司 | 吡唑并嘧啶衍生物、制备方法、药物组合物及用途 |
| US10611766B2 (en) * | 2015-09-16 | 2020-04-07 | Loxo Oncology Inc. | Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer |
| EP3481831B1 (en) * | 2016-07-07 | 2023-09-06 | Daewoong Pharmaceutical Co., Ltd. | 4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and pharmaceutical composition comprising the same |
| AU2017315343A1 (en) * | 2016-08-24 | 2019-02-28 | Arqule, Inc. | Amino-pyrrolopyrimidinone compounds and methods of use thereof |
| WO2019177902A1 (en) * | 2018-03-10 | 2019-09-19 | Yale University | Modulators of btk proteolysis and methods of use |
| US20200038513A1 (en) * | 2018-07-26 | 2020-02-06 | Arvinas Operations, Inc. | Modulators of fak proteolysis and associated methods of use |
| CN118027041A (zh) * | 2019-05-31 | 2024-05-14 | 西藏海思科制药有限公司 | 一种btk抑制剂环衍生物及其制备方法和药学上的应用 |
| WO2020252397A1 (en) * | 2019-06-12 | 2020-12-17 | Baylor College Of Medicine | Small molecule proteolysis-targeting chimeras and methods of use thereof |
| CN112812100B (zh) * | 2019-11-18 | 2022-04-05 | 四川海思科制药有限公司 | 一种具有降解btk激酶的化合物及其制备方法和药学上的应用 |
| CN112979656A (zh) * | 2019-12-12 | 2021-06-18 | 上海美志医药科技有限公司 | 一类靶向降解btk蛋白的化合物 |
-
2022
- 2022-02-02 JP JP2023546433A patent/JP2024505558A/ja not_active Withdrawn
- 2022-02-02 WO PCT/US2022/014830 patent/WO2022169798A2/en not_active Ceased
- 2022-02-02 US US17/591,051 patent/US11530222B2/en active Active
- 2022-02-02 KR KR1020237029298A patent/KR20230142539A/ko active Pending
- 2022-02-02 US US18/263,656 patent/US20240132502A1/en active Pending
- 2022-02-02 EP EP24204895.7A patent/EP4501327A3/en active Pending
- 2022-02-02 ES ES22154786T patent/ES3010513T3/es active Active
- 2022-02-02 EP EP22154786.2A patent/EP4039688B1/en active Active
- 2022-02-02 CN CN202280022626.5A patent/CN117042769A/zh active Pending
- 2022-02-02 FI FIEP22154786.2T patent/FI4039688T3/fi active
- 2022-02-02 CA CA3209082A patent/CA3209082A1/en active Pending
- 2022-02-02 MX MX2023008865A patent/MX2023008865A/es unknown
- 2022-02-02 DK DK22154786.2T patent/DK4039688T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4039688A2 (en) | 2022-08-10 |
| JP2024505558A (ja) | 2024-02-06 |
| KR20230142539A (ko) | 2023-10-11 |
| WO2022169798A2 (en) | 2022-08-11 |
| ES3010513T3 (en) | 2025-04-03 |
| EP4039688B1 (en) | 2024-10-09 |
| CA3209082A1 (en) | 2022-08-11 |
| EP4039688A3 (en) | 2022-11-23 |
| US20240132502A1 (en) | 2024-04-25 |
| MX2023008865A (es) | 2023-08-31 |
| EP4501327A3 (en) | 2025-10-15 |
| WO2022169798A3 (en) | 2022-09-22 |
| EP4501327A2 (en) | 2025-02-05 |
| DK4039688T3 (da) | 2025-01-02 |
| US11530222B2 (en) | 2022-12-20 |
| CN117042769A (zh) | 2023-11-10 |
| US20220259207A1 (en) | 2022-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2437882C2 (ru) | Производные имидазолидинона | |
| HRP20160717T1 (hr) | Kristalne soli inhibitora janus kinaze (r)-3-(4-(7h-pirolo[2,3-d]pirimidin-4-il)-1 h-pirazol-1-il)-3- ciklopentilpropionitril | |
| JP2012501312A5 (cg-RX-API-DMAC7.html) | ||
| JP2020505454A5 (cg-RX-API-DMAC7.html) | ||
| HRP20251479T1 (hr) | Pesticidno aktivni kondenzirani biciklički heteroaromatski spojevi | |
| ES2654847T3 (es) | Compuestos de benzoxazol y benzotiazol sustituidos en 6-O y métodos para inhibir la señalización CSF-1R | |
| JP2008519790A5 (cg-RX-API-DMAC7.html) | ||
| WO2007023111A3 (en) | P38 map kinase inhibitors and methods for using the same | |
| RU2012136643A (ru) | [5,6]- гетероциклическое соединение | |
| NO20064000L (no) | Heteroarylkoblede pyrazoloderivater | |
| NZ589781A (en) | Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases | |
| SI2790705T1 (en) | Use of activity inhibitors or PI3K function | |
| JP2014511355A5 (cg-RX-API-DMAC7.html) | ||
| SI3106463T1 (en) | Substituted pyrazolo(1,5-)pyrimidine compounds as trk kinase inhibitors | |
| NO20082068L (no) | Fremgangsmåter ved anvendelse av 3-(4-amino-1-okso-1,3-dihydro-isoindol-2-yl)-piperidin-2,6-dion ved behandling av visse typer leukemier | |
| ZA200908820B (en) | Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile | |
| CA2551529A1 (en) | Amide derivative and medicine | |
| RU2015106787A (ru) | Замещенные пирролы, активные в качестве ингибиторов киназ | |
| BRPI0606317A2 (pt) | compostos de pirazol, uso dos mesmos e composição farmacêutica | |
| RU2019119899A (ru) | Новое дизамещенное 1,2,4-триазиновое соединение | |
| JP2010513444A5 (cg-RX-API-DMAC7.html) | ||
| ES2342783T3 (es) | Aril aciltioureas sustituidas y compuestos relacionados, inhibidores de la replicacion viral. | |
| RU2010108687A (ru) | Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3 | |
| IL310330A (en) | Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling | |
| JP2010535787A5 (cg-RX-API-DMAC7.html) |